Literature DB >> 3159756

Prevention of autoantibody formation and prolonged survival in New Zealand black/New Zealand white F1 mice fed dehydroisoandrosterone.

J A Lucas, S A Ahmed, M L Casey, P C MacDonald.   

Abstract

Dehydroisoandrosterone, administered orally to New Zealand Black/New Zealand White F1 hybrid mice, prevented the formation of antibodies to double-stranded DNA and prolonged survival in this murine model of lupus erythematosus.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3159756      PMCID： PMC425571          DOI： 10.1172/JCI111929

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


  24 in total

1.  THE NATURAL HISTORY OF AUTOIMMUNE DISEASE IN NZB MICE. A COMPARISON WITH THE PATTERN OF HUMAN AUTOIMMUNE MANIFESTATIONS.

Authors:  M C HOLMES; F M BURNET
Journal:  Ann Intern Med       Date:  1963-09       Impact factor: 25.391

Review 2.  STUDIES ON THE SECRETION AND INTERCONVERSION OF THE ANDROGENS.

Authors:  R L VANDEWIELE; P C MACDONALD; E GURPIDE; S LIEBERMAN
Journal:  Recent Prog Horm Res       Date:  1963

3.  Sex hormone modulation of autoimmunity in NZB/NZW mice.

Authors:  J Roubinian; N Talal; P K Siiteri; J A Sadakian
Journal:  Arthritis Rheum       Date:  1979-11

4.  Therapeutic effects of dehydroepiandrosterone metabolites in diabetes mutant mice (C57BL/KsJ-db/db).

Authors:  D L Coleman; E H Leiter; N Applezweig
Journal:  Endocrinology       Date:  1984-07       Impact factor: 4.736

5.  Delayed androgen treatment prolongs survival in murine lupus.

Authors:  J R Roubinian; N Talal; J S Greenspan; J R Goodman; P K Siiteri
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

6.  Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes-obesity mutants and in aged normal mice.

Authors:  D L Coleman; R W Schwizer; E H Leiter
Journal:  Diabetes       Date:  1984-01       Impact factor: 9.461

7.  Dehydroepiandrosterone: an anti-obesity and anti-carcinogenic agent.

Authors:  A G Schwartz; G C Hard; L L Pashko; M Abou-Gharbia; D Swern
Journal:  Nutr Cancer       Date:  1981       Impact factor: 2.900

8.  Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice.

Authors:  D L Coleman; E H Leiter; R W Schwizer
Journal:  Diabetes       Date:  1982-09       Impact factor: 9.461

9.  Inhibition of 7,12-dimethylbenz[a]anthracene- and urethan-induced lung tumor formation in A/J mice by long-term treatment with dehydroepiandrosterone.

Authors:  A G Schwartz; R H Tannen
Journal:  Carcinogenesis       Date:  1981       Impact factor: 4.944

10.  Prevention of glomerulonephritis and prolonged survival in New Zealand Black/New Zealand White F1 hybrid mice fed an essential fatty acid-deficient diet.

Authors:  E R Hurd; J M Johnston; J R Okita; P C MacDonald; M Ziff; J W Gilliam
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808
View more
  21 in total

1.  The role of endogenous steroid hormones in the generation of T helper 2-mediated autoimmunity in mercuric chloride-treated Brown-Norway rats.

Authors:  I A MacPhee; D R Turner; D B Oliveira
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

2.  Hormonal milieu at time of B cell activation controls duration of autoantibody response.

Authors:  Venkatesh Jeganathan; Elena Peeva; Betty Diamond
Journal:  J Autoimmun       Date:  2014-03-28       Impact factor: 7.094

Review 3.  Systemic lupus erythematosus: Diagnosis and clinical management.

Authors:  Andrea Fava; Michelle Petri
Journal:  J Autoimmun       Date:  2018-11-16       Impact factor: 7.094

Review 4.  The influence of sex hormones on the disease systemic lupus erythematosus.

Authors:  R G Lahita
Journal:  Springer Semin Immunopathol       Date:  1986

5.  Mechanisms of chemoprevention by dietary dehydroisoandrosterone. Inhibition of lymphopoiesis.

Authors:  G Risdon; J Cope; M Bennett
Journal:  Am J Pathol       Date:  1990-04       Impact factor: 4.307

6.  Dehydroepiandrosterone in systemic lupus erythematosus.

Authors:  Amr H Sawalha; Susan Kovats
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

Review 7.  Dehydroepiandrosterone and dehydroepiandrosterone sulphate in atopic allergy and chronic urticaria.

Authors:  Alicja Kasperska-Zajac; Zenon Brzoza; Barbara Rogala
Journal:  Inflammation       Date:  2008-02-21       Impact factor: 4.092

Review 8.  Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action.

Authors:  S Ansar Ahmed; W J Penhale; N Talal
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

9.  Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes in patients with systemic lupus erythematosus (SLE).

Authors:  T Suzuki; N Suzuki; E G Engleman; Y Mizushima; T Sakane
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

Review 10.  Newer drugs for the treatment of lupus nephritis.

Authors:  Dudy G Kuiper-Geertsma; Ronald H W M Derksen
Journal:  Drugs       Date:  2003       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.